Luxembourgers ruffle some feathers for Parkinson’s awareness
Author: Almaz OhenePublished: 14 September 2017
Prep: Cook: Serves:
Parkinson’s activists in Luxembourg City headed to the Grand Ducal Palace for a giant public pillow fight to raise awareness of the condition
Luxembourgers of all ages met at the Grand Ducal Palace in Luxembourg City last weekend, to take part in a public pillow fight in aid of Parkinson’s awareness. It was a symbol of the fight that many in Luxembourg are waging every day against the condition: people with Parkinson’s, their families, doctors and nurses, researchers and many more.
The event’s aim was to raise awareness of the research activities of the National Centre of Excellence in Research on Parkinson’s Disease (NCER-PD), Luxembourg.
Co-organised by the Rotary Clubs Luxembourg, NCER-PD and the Luxembourg Centre for Systems Biomedicine (LCSB) of the University of Luxembourg, opening speeches were given by Lydia Mutsch (Luxembourg Ministry of Health), Professor Rudi Balling (director of the Luxembourg Centre for Systems Biomedicine) and Romain Becker (president of Rotary Interclub Luxembourg). Together, they officially opened proceedings with a pillow fight of their own.
Constant Infalt, country chair and Luxembourg representative of the district governor, said: “We have been supporting biomedical research in Luxembourg for many years.”
To mark the 100th anniversary of the Rotary Foundation, the Rotarians sold pieces of a 100-metre ‘baamkuch’ traditional layer cake to raise money for the NCER-PD. Constant Infalt continued: “With the pillow fight and the sale of our impressive 100-metre baamkuch, we want to generate an especially effective public incentive.”
Throughout the afternoon visitors could also try on a Parkinson’s suit, which simulates the two most representative motor symptoms of Parkinson’s disease: muscle rigidity and tremors. They were also able to test their dexterity, sense of smell and colour vision, to aid understanding of how the brain controls the senses and movements and why Parkinson’s disease affects these features.
L–R: Mars di Bartolomeo, Lydia Mutsch, Rudi Balling, Romain Becker
Professor Rejko Krüger, head of the NCER-PD and neurologist at the Centre Hospitalier de Luxembourg, said: “We are proud to be organising this event in Luxembourg together with the Rotary Club and LCSB and sincerely would like to thank all our partners without whom this event would not have been possible. From the proceeds, we will be funding a project to research the genetic causes of Parkinson’s.”
The disease can be triggered by any number of different genetic or external factors, and one of the problems in Parkinson’s treatment so far is the lack of patient-specific therapies.
“Treatment of this disease has improved considerably in recent years, but there is still a lot to do,” said Professor Krüger. “Only once we have understood the diversity of causes, will we be able to work on developing therapies that take into account the patient’s personal situation. The project that will be funded by the proceeds from this event is another important component in this.”
NCER-PD is a joint initiative of four partners in Luxembourg: Luxembourg Centre for Systems Biomedicine, Centre Hospitalier de Luxembourg, Integrated Biobank of Luxembourg and Luxembourg Institute of Health, which are uniting their efforts and expertise to develop new methods for the early diagnosis and treatment of Parkinson’s disease. The Luxembourg Parkinson’s study NCER-PD has been funded by the Luxembourg National Research Fund since 2015.
The LCSB is a biomedical research centre of the University of Luxembourg. It is accelerating biomedical research by closing the link between systems biology and medical research. Collaboration between biologists, medical doctors, computer scientists, physicists, engineers and mathematicians is offering new insights into complex systems like biological cells, organs, and organisms.
One symbol, one voice: ramping up the voltage on World Parkinson’s Day
Take part in a global Parkinson’s disease initiative
6 days ago
Could certain cancers be linked to Parkinson’s disease?
Previous research has suggested that people with Parkinson’s may generally be less likely to develop most cancers. However, a new international study has found a potential genetic link between certain types of cancer and the condition. The team analysed genetic data from genome-wide association studies – a research approach that aims to identify gene variations associated with disease risk – to recognise common genetic risk factors between cancer and Parkinson’s. The findings uncovered a genetic link between the condition and both prostate cancer and melanoma. Meanwhile, the sum of various gene variants (otherwise known as the polygenic risk score) that contribute to Parkinson’s was significantly associated with a higher risk of breast cancer. “Our results suggest the importance of shared genetic variants between Parkinson’s and some cancers,” the researchers concluded in the study, which was published in the medical journal ‘Movement Disorders’. They highlighted the need for further studies to…
Investigational Parkinson’s disease dementia therapy fails in clinical trial
Research into new potential therapies for people with Parkinson’s is complex, which means that not all clinical trials will successfully move on to the next phase. This proved to be the case for US biotech company Aptinyx, which announced that it will halt further development work on an investigational therapy following “disappointing” results in the second phase of its study. The research had set out to examine the effect of NYX-458 – an oral therapy created to modulate the activity of receptors in the brain that are responsible for communication between neurons. The aim of the therapy was to improve cognition in people with cognitive impairment linked to Parkinson’s or Lewy body dementia. Yet, when compared to a placebo, the therapy didn’t demonstrate “meaningful improvements” in cognitive function. Dr Andy Kidd, president and CEO at Aptinyx, said: “We are very disappointed that the results of this Phase 2 study did…
A new intimacy guide aims to support people with Parkinson’s disease in the US
Does sexual wellness in the Parkinson’s community need more focus? It’s an area that the American Parkinson Disease Association (APDA) and media brand Havas Health Plus have targeted through the launch of a free intimacy guide. Available to people in the US, ‘The ParkinSex Booklet & Kit’ aims to support those whose relationships may have been impacted by emotional and physical distance linked to the condition. Alongside an educational guide, the kit includes items such as candles, coupons for adaptative clothing and massage stones. Following a positive response to an initial pilot distribution of the guides in the US, there is now a waitlist for future kits. Commenting on the launch in a press release, APDA president and CEO Leslie Chambers said: “The challenges of Parkinson’s can often result in intimacy and connection getting left behind. This is why we created ‘The ParkinSex Booklet & Kit’, to help people with…